These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 28229991)

  • 1. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
    Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
    Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muckle-Wells Syndrome: A Case Report with an NLRP3 T348M Mutation.
    Naz Villalba E; Gomez de la Fuente E; Caro Gutierrez D; Pinedo Moraleda F; Yanguela Rodilla J; Mazagatos Angulo D; López Estebaranz JL
    Pediatr Dermatol; 2016 Sep; 33(5):e311-4. PubMed ID: 27435956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 A439V Mutation in a Large Family with Cryopyrin-associated Periodic Syndrome: Description of Ophthalmologic Symptoms in Correlation with Other Organ Symptoms.
    Sobolewska B; Angermair E; Deuter C; Doycheva D; Kuemmerle-Deschner J; Zierhut M
    J Rheumatol; 2016 Jun; 43(6):1101-6. PubMed ID: 27134254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature.
    Liu J; Zhang R; Yi Z; Lin Y; Chang H; Zhang Q
    Pediatr Rheumatol Online J; 2023 Feb; 21(1):15. PubMed ID: 36765385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
    Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM
    Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.
    Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S
    Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.
    Samson JM; Ravindran Menon D; Vaddi PK; Kalani Williams N; Domenico J; Zhai Z; Backos DS; Fujita M
    Front Immunol; 2020; 11():584364. PubMed ID: 33329557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
    Sarrabay G; Grandemange S; Touitou I
    Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle-Wells syndrome.
    Kaneko N; Kurata M; Yamamoto T; Shigemura T; Agematsu K; Yamazaki T; Takeda H; Sawasaki T; Koga T; Kawakami A; Yachie A; Migita K; Yoshiura KI; Urano T; Masumoto J
    Sci Rep; 2020 Aug; 10(1):13562. PubMed ID: 32782316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetics of cryopyrin-associated periodic syndrome].
    Kümmerle-Deschner JB; Lohse P
    Z Rheumatol; 2017 May; 76(4):313-321. PubMed ID: 28197772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
    Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
    Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
    Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
    J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
    Yadlapati S; Efthimiou P
    Mod Rheumatol; 2016; 26(1):3-8. PubMed ID: 26140469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two adult siblings with atypical cryopyrin-associated periodic syndrome due to a novel M299V mutation in NLRP3.
    Verma D; Eriksson P; Sahdo B; Persson A; Ejdebäck M; Särndahl E; Söderkvist P
    Arthritis Rheum; 2010 Jul; 62(7):2138-43. PubMed ID: 20506209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review.
    Başaran Ö; Uncu N; Çakar N; Turanlı ET; Kiremitci S; Aydın F; Bayrakcı US
    Rheumatol Int; 2018 Aug; 38(8):1571-1576. PubMed ID: 29951964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.
    Hedrich CM; Bruck N; Paul D; Hahn G; Gahr M; Rösen-Wolff A
    Rheumatol Int; 2012 Sep; 32(9):2629-36. PubMed ID: 21833523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
    Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S
    J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes.
    Nakagawa K; Gonzalez-Roca E; Souto A; Kawai T; Umebayashi H; Campistol JM; Cañellas J; Takei S; Kobayashi N; Callejas-Rubio JL; Ortego-Centeno N; Ruiz-Ortiz E; Rius F; Anton J; Iglesias E; Jimenez-Treviño S; Vargas C; Fernandez-Martin J; Calvo I; Hernández-Rodríguez J; Mendez M; Dordal MT; Basagaña M; Bujan S; Yashiro M; Kubota T; Koike R; Akuta N; Shimoyama K; Iwata N; Saito MK; Ohara O; Kambe N; Yasumi T; Izawa K; Kawai T; Heike T; Yagüe J; Nishikomori R; Aróstegui JI
    Ann Rheum Dis; 2015 Mar; 74(3):603-10. PubMed ID: 24326009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.